Baillie Gifford & Co’s Kite Pharma, Inc. KITE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,754	Closed	-$495K	–	208
2017 Q3	$495K	Buy	2,754 +190	+7%	+$34.2K	﹤0.01%	196
2017 Q2	$266K	Hold	2,564	–	–	﹤0.01%	201
2017 Q1	$201K	Buy	+2,564	New	+$201K	﹤0.01%	200